Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yaming Li

Showing results (221-230 of 280) with videos related to

Pageof 28
Sort By:
Molecular Cancer|June 7, 2024
Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancerYiran Liang, Fangzhou Ye, Dan Luo, et al.
Research (Washington, D.C.)|July 30, 2025
EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast CancerYajie Wang, Yiran Liang, Dan Luo, et al.
Cell Death & Disease|July 30, 2024
Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4<sup>+</sup>T cell activation in breast cancerXi Chen, Chenao Ma, Yaming Li, et al.
Frontiers in Oncology|September 13, 2021
Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer PatientsXiaolong Wang, Chen Li, Tong Chen, et al.
Molecular Therapy. Nucleic Acids|April 25, 2020
circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 FamilyXiaojin Song, Yiran Liang, Yuting Sang, et al.
Cancer Biology & Therapy|January 3, 2018
Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancerYiran Liang, Yaming Li, Xiaojin Song, et al.
Cell Death & Disease|May 13, 2018
A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancerYiran Liang, Xiaojin Song, Yaming Li, et al.
Cell Death & Disease|July 31, 2023
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cellsZheng Li, Yaming Li, Dianwen Han, et al.
Virology Journal|June 10, 2010
Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particlesNarasimhan J Venkatachari, Leah A Walker, Oznur Tastan, et al.
Journal of Addiction Medicine|March 12, 2026
Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use DisorderPayel Jhoom Roy, Nalingna Yuan, Yaming Li, et al.
Pageof 28

Showing results (221-230 of 280) with videos related to

Sort By:
Pageof 28
Molecular Cancer|June 7, 2024
Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancerYiran Liang, Fangzhou Ye, Dan Luo, et al.
Research (Washington, D.C.)|July 30, 2025
EDEM1 Inhibits Endoplasmic Reticulum Stress to Induce Doxorubicin Resistance through Accelerating ERAD and Activating Keap1/Nrf2 Antioxidant Pathway in Triple-Negative Breast CancerYajie Wang, Yiran Liang, Dan Luo, et al.
Cell Death & Disease|July 30, 2024
Trim21-mediated CCT2 ubiquitination suppresses malignant progression and promotes CD4<sup>+</sup>T cell activation in breast cancerXi Chen, Chenao Ma, Yaming Li, et al.
Frontiers in Oncology|September 13, 2021
Identification and Validation of a Five-Gene Signature Associated With Overall Survival in Breast Cancer PatientsXiaolong Wang, Chen Li, Tong Chen, et al.
Molecular Therapy. Nucleic Acids|April 25, 2020
circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 FamilyXiaojin Song, Yiran Liang, Yuting Sang, et al.
Cancer Biology & Therapy|January 3, 2018
Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancerYiran Liang, Yaming Li, Xiaojin Song, et al.
Cell Death & Disease|May 13, 2018
A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancerYiran Liang, Xiaojin Song, Yaming Li, et al.
Cell Death & Disease|July 31, 2023
circRNA-SFMBT2 orchestrates ERα activation to drive tamoxifen resistance in breast cancer cellsZheng Li, Yaming Li, Dianwen Han, et al.
Virology Journal|June 10, 2010
Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particlesNarasimhan J Venkatachari, Leah A Walker, Oznur Tastan, et al.
Journal of Addiction Medicine|March 12, 2026
Longitudinal Patterns of Dental Health Care Utilization 18 Months Before and 36 Months After Initiation of Index Medications for Opioid Use DisorderPayel Jhoom Roy, Nalingna Yuan, Yaming Li, et al.
Pageof 28